
Advances in Chemotheraphy
Volume 1
- 1st Edition - January 1, 1964
- Imprint: Academic Press
- Editors: Abraham Goldin, F. Hawking
- Language: English
- Paperback ISBN:9 7 8 - 1 - 4 8 3 2 - 1 0 8 9 - 6
- Hardback ISBN:9 7 8 - 1 - 4 8 3 1 - 9 9 2 9 - 0
- eBook ISBN:9 7 8 - 1 - 4 8 3 2 - 2 4 3 2 - 9
Advances in Chemotherapy, Volume 1 presents the significant progress both in theoretical and experimental aspects in the various disciplines comprising chemotherapy field. This… Read more

Purchase options

Institutional subscription on ScienceDirect
Request a sales quoteAdvances in Chemotherapy, Volume 1 presents the significant progress both in theoretical and experimental aspects in the various disciplines comprising chemotherapy field. This volume is divided into nine chapters, and begins with an introduction to the historical developments in chemotherapy. The subsequent chapters deal with the nature, use, and limitations of drug predictive systems and the experimental results concerning the trypanocidal activity of phenanthridine and aminoquinaldine. These topics are followed by discussions on chemoprophylaxis and chemotherapy of tumor viruses, the antitumor activity of alkaloidal substances from Vinca rosea plant, and the correlation between inhibitory activity in mammalian cell assays and experimental antitumor activity. A chapter considers the interplay of immune mechanisms and drugs in the clinical and veterinary aspects of antiparasitic chemotherapy. The final chapters look into some of the pharmacological, therapeutic, and biochemical bases for the combined actions of drugs, with special emphasis on the combination chemotherapy of cancer and factors which may influence its effectiveness. These chapters also describe the concept of using inhibitors in chemotherapy. This book will prove useful to oncologists and other workers in the medical profession with background of chemotherapy.
List of Contributors
Preface
Historical Perspectives in Chemotherapy
Quantitative Concepts in the Clinical Study of Drugs
I. Introduction
II. Preclinical Studies
III. Clinical Considerations
IV. Summary
References
Mechanisms of Action of Phenanthridine and Aminoquinaldine Trypanocides
I. Introduction
II. Trypanosomiasis in Africa: Present-Day Aspects
III. Problems Peculiar to Studies of the Mode of Action of Trypanocides: Blood-Stream and Culture Forms of Trypanosomes
IV. Use of an Insect Flagellate as a Test System for Studies on Drug Action: Advantages and Limitations
V. Drugs in Use for Treatment of Trypanosomiasis in Cattle
VI. Characteristics of the Trypanocidal Action of Phenanthridines and Aminoquinaldines: In Vivo Studies
VII. In Vitro Studies Using Crithidia oncopelti as Test Organism
VIII. Effects of Phenanthridines on Other Cell Systems
IX. Drug Resistance to Phenanthridines and Aminoquinaldines
X. Mechanisms of Action and the Problem of Selective Toxicity: Conclusions and Speculations
References
Chemoprophylaxis and Chemotherapy of Viral Diseases
I. Introduction
II. Factors Influencing Recovery from Viral Diseases
III. Materials with Chemoprophylactic or Chemotherapeutic Activity
IV. Tumor Viruses
V. Comment
References
The Vinca Alkaloids
1. General Introduction
II. Preparation, Chemistry, and Structural Relationships
III. Experimental Biological Properties
IV. Clinical Experiences
V. Summary
References
Cell Culture and Cancer Chemotherapy
I. Introduction
II. Methods
III. Cell Lines
IV. Nutritional and Biochemical Studies
V. Growth-Regulatory Factors
VI. Maintenance and Loss of Specific Functional Capacities
VII. Mammalian Cell Cultures as an Assay for Potential Antitumor Activity
VIII. Organ Culture
IX. Comment
References
Immunoreactions in Antiparasitic Chemotherapy
I. Introduction
II. Components of the Drug-Host-Parasite Complex
III. Immunoreactions in Experimental Antiparasitic Chemotherapy
IV. Immunoreactions in Antiparasitic Chemotherapy in the Clinic and in the Field
References
Drug Synergism in Antineoplastic Chemotherapy
I. The Concept of Therapeutic Synergism
II. Parameters of Response to Therapy of Neoplastic Disease
III. The Pharmacological and Therapeutic Bases for Synergism
IV. The Biochemical Basis for Antitumor Synergism
V. Combination Chemotherapy of Cancer Patients
VI. Conclusions
References
New Concepts of the Use of Inhibitors in Chemotherapy
I. The Classical Antimetabolite Approach
II. New Inhibitors Based on Allosteric Inhibition
III. Enzyme Subunits and Allosteric Phenomena
IV. Multiple Forms of Enzymes
V. Sulfanilamide Inhibition and Folic Acid Synthesis
VI. Virus-Induced Enzymes
VII. Lethal Synthesis and Feedback Inhibition
VIII. DPN Analogs
IX. Homofolate
X. New Inhibitors that Interfere with or Redirect Information Transfer
XI. Mechanism of Actinomycin Inhibition
XII. Hormone Effects
XIII. Specific Inhibition of DNA Replication
XIV. Drugs that Directly Influence Mitotic Processes
XV. Conclusion
References
Author Index
Subject Index
- Edition: 1
- Published: January 1, 1964
- No. of pages (eBook): 592
- Imprint: Academic Press
- Language: English
- Paperback ISBN: 9781483210896
- Hardback ISBN: 9781483199290
- eBook ISBN: 9781483224329
FH
F. Hawking
Affiliations and expertise
Clinical Research Centre, Harrow, Middlesex, EnglandRead Advances in Chemotheraphy on ScienceDirect